Drugs / MVA MSP1
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01142765 | Jun 2010 → Mar 2011 | malaria | University of Oxford | Completed | No outcome recorded |
| Phase 1/2 | NCT01003314 | Nov 2009 → Sep 2010 | malaria | University of Oxford | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MVA-MSP1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01003314 ↗ |
| Modality | Vaccine | “two new malaria vaccines AdCh63 MSP1 and MVA MSP1” NCT01003314 ↗ |
| Route | Intramuscular | “single dose of MVA-MSP1 vaccine 5 x 10\^8 vp administered IM 8 weeks later” NCT01003314 ↗ |